XML 49 R25.htm IDEA: XBRL DOCUMENT
v3.20.2

Note 4 - Acquisitions (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2020
Notes Tables |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] |
|  | B-MoGen Biotechnologies |  |  | Exosome Diagnostics |  |  | Quad Technologies |  |  | Trevigen |  |  | Atlanta Biologicals |  |  | Eurocell Diagnostics |
Current assets, net of cash |  | $ | 504 |  |  | $ | 2,611 |  |  | $ | 36 |  |  | $ | 1,662 |  |  | $ | 15,722 |  |  | $ | 512 |
Equipment and other long-term assets |  |  | 269 |  |  |  | 2,212 |  |  |  | 228 |  |  |  | 53 |  |  |  | 4,901 |  |  |  | 188 |
Intangible assets: |
Developed technology |  |  | 14,000 |  |  |  | 105,000 |  |  |  | 12,256 |  |  |  | 5,100 |  |  |  | 23,000 |  |  |  | - |
Trade name |  |  | - |  |  |  | 58,000 |  |  |  | - |  |  |  | 160 |  |  |  | 2,300 |  |  |  | - |
Customer relationships |  |  | 400 |  |  |  | 2,300 |  |  |  | - |  |  |  | 260 |  |  |  | 3,600 |  |  |  | 6,272 |
Goodwill |  |  | 16,131 |  |  |  | 105,362 |  |  |  | 14,481 |  |  |  | 5,991 |  |  |  | 10,195 |  |  |  | 2,910 |
Total assets acquired |  |  | 31,304 |  |  |  | 275,485 |  |  |  | 27,001 |  |  |  | 13,226 |  |  |  | 59,718 |  |  |  | 9,882 |
Liabilities |  |  | 211 |  |  |  | 3,716 |  |  |  | 296 |  |  |  | 387 |  |  |  | 90 |  |  |  | 483 |
Deferred income taxes, net |  |  | 3,051 |  |  |  | 16,346 |  |  |  | 943 |  |  |  | 2,195 |  |  |  | 8,354 |  |  |  | 2,070 |
Net assets acquired |  | $ | 28,042 |  |  | $ | 255,423 |  |  | $ | 25,762 |  |  | $ | 10,644 |  |  | $ | 51,274 |  |  | $ | 7,329 |
Cash paid, net of cash acquired |  |  | 17,448 |  |  |  | 251,623 |  |  |  | 20,462 |  |  | $ | 10,644 |  |  | $ | 51,274 |  |  | $ | 5,933 |
Consideration payable |  |  | 5,500 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 1,396 |
Contingent consideration payable |  |  | 5,094 |  |  |  | 3,800 |  |  |  | 5,300 |  |  |  | - |  |  |  | - |  |  |  | - |
Net assets acquired |  | $ | 28,042 |  |  | $ | 255,423 |  |  | $ | 25,762 |  |  | $ | 10,644 |  |  | $ | 51,274 |  |  | $ | 7,329 |

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration